We’ve stated on a few occasions now that the raft of EU legislation will see the demolition of alternative medicine and its therapies within five years. Some have accused us of scare-mongering. The measures, they say, aren’t that bad.
Well, if we’re wrong, we’ll eat our stethoscope, but look out for the early warning signs. One came just the other day from the UK’s Medicines Control Agency, which has banned two products that contain evening primrose oil.
The products are Epogam, for the treatment of atopic eczema, and Efamast, which treats mastalgia (breast pain). Both contain gamolenic acid, which is derived from Evening Primrose Oil.
The MCA ban is strange on two counts. First, the MCA admits there has never been any health risks associated with the products, and its decision is contrary to the guidelines of the National Health Service, which advocates the use of gamolenic acid for the treatment of mastalgia.
So is this a portent of things to come? Don’t forget, the MCA will gain enormous powers under one EU directive, which will give it the right to control any product that claims to have an efficacious effect. As every alternative and complementary product obviously makes such a claim, so they will fall under the watchful gaze of the MCA.
To help us fight the EU directives, visit the Health Freedom Movement website and make a donation. You’ll find it on: http://www.healthfreedommovement.com